High constant incidence rates of second cutaneous melanomas
- PMID: 15957164
- DOI: 10.1002/ijc.21262
High constant incidence rates of second cutaneous melanomas
Abstract
The incidence of most epithelial cancers rises with a power of age. However, second breast cancers have a high constant incidence independent of age. The skin is one of the few other sites allowing examination of age incidence curves of second neoplasms of the same organ. We considered the risk of second primary cutaneous malignant melanoma (CMM) in a population-based series of 3,439 first CMM registered and followed-up between 1974 and 2003 in the Swiss Cantons of Vaud and Neuchâtel (about 786,000 inhabitants). A total of 43 cases of second CMM were observed vs. 9.3 expected, corresponding to a standardized incidence ratio (SIR) of 4.6. The SIR was 8.5 under age 50, 5.7 at age 50-59 and 3.5 at age 60 or over. At 20 years, the cumulative risk of second CMM was 5%. Age-specific incidence rates of second primary CMM did not vary across age groups 30-39 through 80+, ranging between 1 and 2.5 per 1,000 person-years. Thus, the risk of CMM is substantially increased in subjects diagnosed with a CMM, and the relative risk is greater at younger age and declines with advancing age. The high constant incidence curve of second CMM is compatible with the occurrence of a single mutational event in a population of susceptible individuals.
Copyright 2005 Wiley-Liss, Inc
Similar articles
-
Incidence of invasive cancers following cutaneous malignant melanoma.Int J Cancer. 1997 Sep 4;72(5):776-9. doi: 10.1002/(sici)1097-0215(19970904)72:5<776::aid-ijc12>3.0.co;2-7. Int J Cancer. 1997. PMID: 9311593
-
High constant incidence rates of second primary neoplasms.Eur J Cancer Prev. 2008 Oct;17(5):385-8. doi: 10.1097/CEJ.0b013e3282f75f57. Eur J Cancer Prev. 2008. PMID: 18714177
-
Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland.Melanoma Res. 2005 Feb;15(1):73-5. doi: 10.1097/00008390-200502000-00012. Melanoma Res. 2005. PMID: 15714124
-
[The sun and malignant melanoma].Hautarzt. 1992 May;43(5):251-7. Hautarzt. 1992. PMID: 1612913 Review. German.
-
Socioeconomic status and cutaneous malignant melanoma in Northern Europe.Br J Dermatol. 2014 Apr;170(4):787-93. doi: 10.1111/bjd.12800. Br J Dermatol. 2014. PMID: 24359255 Review.
Cited by
-
Melanoma epidemiology, biology and prognosis.EJC Suppl. 2013 Sep;11(2):81-91. doi: 10.1016/j.ejcsup.2013.07.012. EJC Suppl. 2013. PMID: 26217116 Free PMC article. Review. No abstract available.
-
Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.Metabolomics. 2018 Aug 3;14(8):105. doi: 10.1007/s11306-018-1398-9. Metabolomics. 2018. PMID: 30830422
-
Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study.J Natl Cancer Inst. 2021 Mar 1;113(3):318-328. doi: 10.1093/jnci/djaa088. J Natl Cancer Inst. 2021. PMID: 32577730 Free PMC article.
-
Magnetic nanoparticles in theranostics of malignant melanoma.EJNMMI Res. 2021 Dec 14;11(1):127. doi: 10.1186/s13550-021-00868-6. EJNMMI Res. 2021. PMID: 34905138 Free PMC article. Review.
-
CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.Acta Derm Venereol. 2018 Oct 10;98(9):862-866. doi: 10.2340/00015555-2969. Acta Derm Venereol. 2018. PMID: 29774366 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical